Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion

Bioinformatics

Volumn 30, Issue 21, 2014, Pages 3036-3043

  Bollig Fischer, Aliccia ^a,b   Marchetti, Luca ^c,d   Mitrea, Cristina ^e   Wu, Jiusheng ^a,b   Kruger, Adéle ^b   Manca, Vincenzo ^c   Drəghici, Sorin ^b,e  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VERONA   (Italy)

^d MICROSOFT RESEARCH   (United States)

^e Wayne State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E2F2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTOME;

BIOLOGICAL MODEL; BREAST TUMOR; CELL ADHESION; CELL MEMBRANE; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL-MATRIX JUNCTIONS; E2F2 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, ERBB-2; HUMANS; MODELS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; UP-REGULATION;

EID: 84911436760     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu400     Document Type: Article

References (43)

1. Bansal, M. et al. (2007) How to infer gene networks from expression profiles. Mol. Syst. Biol., 3, 78.
2. Bollig-Fischer, A. et al. (2010) HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. Cancer Res., 70, 7862-7873.
3. Bollig-Fischer, A. et al. (2011) Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. PLoS One, 6, e17959.
4. Chakraborty, G. et al. (2012) Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS One, 7, e33633.
5. Charafe-Jauffret, E. et al. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res., 69, 1302-1313.
6. Chen, H.Z. et al. (2009) Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer, 9, 785-797.
7. Diehl, K.M. et al. (2007) p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal. J. Surg. Res., 142, 162-169.
8. Draghici, S. et al. (2007) A systems biology approach for pathway level analysis. Genome Res., 17, 1537-1545.
9. Eisen, M.B. et al. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA, 95, 14863-14868.
10. Forozan, F. et al. (1999) Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br. J. Cancer, 81, 1328-1334.
11. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
12. Hanson, J.L. et al. (2004) The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation. Cancer Res., 64, 7248-7255.
13. Ideker, T. et al. (2011) Boosting signal-to-noise in complex biology: prior knowledge is power. Cell, 144, 860-863.
14. Ivanova, I.A. et al. (2013) FER kinase promotes breast cancer metastasis by regulating 6- and 1-integrin-dependent cell adhesion and anoikis resistance. Oncogene, 32, 5582-5592.
15. Jordan, V.C. (2008) Tamoxifen: catalyst for the change to targeted therapy. Eur. J. Cancer, 44, 30-38.
16. Jornsten, R. et al. (2011) Network modeling of the transcriptional effects of copy number aberrations in glioblastoma. Mol. Syst. Biol., 7, 486-503.
17. Khatri, P. et al. (2005) Recent additions and improvements to the Onto-Tools. Nucleic Acids Res., 33, W762-W765.
18. Korkaya, H. et al. (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene, 27, 6120-6130.
19. Kuperwasser, C. et al. (2005) A mouse model of human breast cancer metastasis to human bone. Cancer Res., 65, 6130-6138.
20. Lees, J.A. et al. (1993) The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol., 13, 7813-7825.
21. Lockhart, D.J. and Winzeler, E.A. (2000) Genomics, gene expression and DNA arrays. Nature, 405, 827-836.
22. Luo, J. et al. (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell, 136, 823-837.
23. Manca, V. (2008) The metabolic algorithm for P systems: principles and applications. Theor. Comput. Sci., 404, 142-155.
24. Manca, V. (2013) Infobiotics: Information in Biotic Systems. Vol. 3, Springer, Berlin Heidelberg.
25. Manca, V. and Marchetti, L. (2011) Log-gain stoichiometric stepwise regression for MP systems. Int. J. Found. Comput. Sci., 22, 97-106.
26. Manca, V. andMarchetti, L. (2012) Solving dynamical inverse problems by means of metabolic P systems. Biosystems, 109, 78-86.
27. Marchetti, L. and Manca, V. (2012) A methodology based on MP theory for gene expression analysis. Lect. Notes Comput. Sci., 7184, 300-313.
28. Marella, N.V. et al. (2009) Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines. Cancer Res., 69, 5946-5953.
29. Matys, V. et al. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res., 31, 374-378.
30. Miller, F.R. et al. (1993) Xenograft model of progressive human proliferative breast disease. J. Natl Cancer. Inst., 85, 1725-1732.
31. Miller, T.W. et al. (2011) ERalpha-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Cancer Discov., 1, 338-351.
32. Mosca, E. et al. (2010) A multilevel data integration resource for breast cancer study. BMC Syst. Biol., 4, 76.
33. Norris, J.L. and Baldwin, A.S. Jr. (1999) Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J. Biol. Chem., 274, 13841-13846.
34. Pradeep, C.R. et al. (2012) Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene, 31, 907-917.
35. Ramaswamy, S. et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl Acad. Sci. USA, 98, 15149-15154.
36. Ramoni, M.F. et al. (2002) Cluster analysis of gene expression dynamics. Proc. Natl Acad. Sci. USA, 99, 9121-9126.
37. Rhodes, D.R. et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia, 6, 1-6.
38. Saeki, Y. et al. (2009) Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells. BMC Genomics, 10, 545-561.
39. Sharma, S.V. and Settleman, J. (2007) Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev., 21, 3214-3231.
40. Shibue, T. and Weinberg, R.A. (2009) Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl Acad. Sci. USA, 106, 10290-10295.
41. Tibbles, L.A. and Woodgett, J.R. (1999) The stress-activated protein kinase pathways. Cell. Mol. Life Sci., 55, 1230-1254.
42. Venet, D. et al. (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput. Biol., 7, e1002240.
43. Wagle, N. et al. (2011) Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling. J. Clin. Oncol., 29, 3085-3896.